12

nanotimes

Companies Facts

Degeneration and general corporate purposes. ACT expects to end the year with approximately $15 mil- lion in cash and equivalents, and less than $1 million of debt. The Company recently strengthened its ba- lance sheet by selling 750 shares of non-convertible Series B Preferred Stock to Optimus Life Sciences Capital Partners, LLC under a previously announced $10 million Preferred Stock transaction. ACT also eliminated more than $10 million of indebtedness through conversions and settled more than $10 milli- on of other liabilities. http://www.advancedcell.com

contract with the Hawai‘i Natural Energy Institute (HNEI) of the University of Hawai‘i at Manoa to sup- ply a one-megawatt ALTI-ESS energy storage system for a test of wind energy integration. The system will be installed at the Hawi wind farm on the island of Hawai‘i and connected to the Hawai‘i Electric Light Company (HELCO) utility grid. The equipment purchase and associated service contracts, valued at approximately $1.8 million dollars, require Altairna- no to build, ship, install and commission its ALTI-ESS advanced energy storage system, and provide tech- nical support and system monitoring and reporting over a period of three years. The project is expected to be operational by the third quarter of 2011. http://www.altairnano.com

A F

or the fourth quarter of 2010, AMCOL Internatio- nal Corporation (NYSE: ACO) reports a loss attri-

butable to AMCOL shareholders of $0.30 per diluted share compared to earnings of $0.36 per diluted share in the 2009 period. However, these losses re- sult largely from unusual items recorded in the fourth

ltair Nanotechnologies, Inc. (Altairnano, NASDAQ: ALTI) had been awarded a firm

quarter of 2010. Excluding these unusual items, we generated net income attributable to AMCOL share- holders of $0.21 per diluted share as compared to the prior year amount of $0.31 per diluted share, which has also been adjusted for unusual items. Net sales increased 26.4% to $223.4 million for the quar- ter ended December 31, 2010, compared to $176.7 million for the 2009 period. Operating profit increa- sed by 11.6% over the 2009 period to $11.5 million. Foreign currency translation did not have a material impact on our comparative results for the quarter.

Long-term debt increased $29.2 million to $236.2 million during our 2010 fiscal year. Net working capital increased $45.4 million during the year to $249.1 million at December 31, 2010. The increase in working capital was due to increased sales vo- lumes.

http://www.amcol.com

SCIL (Substrate Conformal Imprint Lithography) with UV curing material. AMO has provided two key components for this development: the master for large-area nanostructures and the UV-curing nanoim- print material AMONIL. The masters, with a size up to 6inch, are fabricated at AMO by laser interference lithography and plasma etching in Silicon. They have perfect binary periodic patterns between 180 to 2.500nm. These holographic gratings are cha- racterized by absolutely seamless patterns and a low defect-density on a large area, due to a special fabri- cation technology. http://www.amo.de

A

MO in Germany and SUSS MicroTec AG are working on the development of applications for

11-01 :: December 2010 / January 2011